Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Luminex Corporation    LMNX

LUMINEX CORPORATION (LMNX)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/16/2018 07/17/2018 07/18/2018 07/19/2018 07/20/2018 Date
31.82(c) 33.63(c) 33.4(c) 33.99(c) 33.32(c) Last
326 006 678 908 416 720 375 272 283 660 Volume
+0.19% +5.69% -0.68% +1.77% -1.97% Change
More quotes
Financials (USD)
Sales 2018 315 M
EBIT 2018 39,1 M
Net income 2018 28,8 M
Finance 2018 162 M
Yield 2018 0,72%
Sales 2019 322 M
EBIT 2019 46,3 M
Net income 2019 27,1 M
Finance 2019 196 M
Yield 2019 0,84%
P/E ratio 2018 47,60
P/E ratio 2019 49,00
EV / Sales2018 4,29x
EV / Sales2019 4,08x
Capitalization 1 511 M
More Financials
Company
Luminex Corp. develops, manufactures and markets proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries.The company was founded by Mark B. Chandler and Van S. Chandler in May 1995 and is headquartered in Austin, TX. 
More about the company
Surperformance© ratings of Luminex Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on LUMINEX CORPORATION
07/17LUMINA GOLD : Announces C$7 Million Private Placement of Common Shares
AQ
07/13LUMINEX CORPORATION : Second Quarter Earnings Release Scheduled for August 6, 20..
PR
06/29LUMINEX : Navy Seeks Luminex Products in San Diego, California
AQ
06/25INSIDER TRADING ACTIVITY LUMINEX CO. : LMNX) – Director Sold 40,797 shares..
AQ
06/21LUMINEX CORPORATION : Ex-dividend day for
FA
06/14LUMINEX : Chemical reagents
AQ
06/13LUMINEX : Initiates Clinical Trials for VERIGENE® II Gastrointestinal Assay
PU
06/07LUMINEX : Patent Issued for Apparatus, System, and Method for Image Normalizatio..
AQ
05/31LUMINEX CORPORATION : to Present at Upcoming Healthcare Investor Conferences
AQ
05/29LUMINEX : Acquisition of Luminex branded items.
AQ
More news
Sector news : Advanced Medical Equipment & Technology - NEC
07/20Impact of U.S-China trade tariffs on U.S. companies
RE
07/19INTUITIVE SURGICAL : Quarterly Results Beat Wall Street Targets -- Earnings Revi..
DJ
07/19Danaher on Track for New All-Time High After Dental Spinoff Plan -- Data Talk
DJ
07/19DANAHER : to Spin off Dental Business -- Update
DJ
07/19DANAHER : 2Q Profit Up 20%, Raises Guidance
DJ
More sector news : Advanced Medical Equipment & Technology - NEC
Latest Tweets
01:16aLuminex Co. $LMNX Expected to Announce Earnings of $0.20 Per Share  
07/21Luminex $LMNX Upgraded by ValuEngine to “Strong-Buy”  
07/14Luminex Corporation Second Quarter Earnings Release Scheduled for August 6, 2.. 
07/13$LMNX Luminex Corporation Second Quarter Earnings Release Scheduled for Augus.. 
07/11Contrasting Orthopediatrics $KIDS and Luminex $LMNX  
More tweets
Qtime:84
News from SeekingAlpha
06/13Luminex launches clinical studies of Verigene II GI assay 
05/18Luminex declares $0.06 dividend 
05/07Luminex Corporation's (LMNX) CEO Homi Shamir on Q1 2018 Results - Earnings Ca.. 
05/07Luminex Q1 top line up 6%; earnings up 46% 
05/07Luminex beats by $0.10, beats on revenue 
Chart LUMINEX CORPORATION
Duration : Period :
Luminex Corporation Technical Analysis Chart | LMNX | US55027E1029 | 4-Traders
Technical analysis trends LUMINEX CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 7
Average target price 22,2 $
Spread / Average Target -33%
EPS Revisions
Managers
NameTitle
G. Walter Loewenbaum Chairman
Harriss T. Currie Chief Financial Officer, Treasurer & SVP-Finance
Charles J. Collins Vice President-Research & Development
David B. Oldham Vice President-Systems Research & Development
Thomas W. Erickson Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
LUMINEX CORPORATION69.14%1 511
THERMO FISHER SCIENTIFIC14.20%86 934
DANAHER CORPORATION9.13%72 093
INTUITIVE SURGICAL41.61%59 060
BOSTON SCIENTIFIC CORPORATION36.22%46 527
ILLUMINA42.41%45 438